|
CPNE3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.7715611723761E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.34590000000235E-05 |
| Normal-vs-Stage3 |
1.587980E-04 |
| Normal-vs-Stage4 |
4.107500E-02 |
| Stage1-vs-Stage2 |
2.177600E-01 |
| Stage1-vs-Stage3 |
3.630400E-02 |
| Stage1-vs-Stage4 |
1.177590E-01 |
| Stage2-vs-Stage3 |
6.147800E-01 |
| Stage2-vs-Stage4 |
5.872800E-01 |
| Stage3-vs-Stage4 |
8.758600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.78469477979593E-11 |
| Normal-vs-Asian |
7.882100E-02 |
| Caucasian-vs-AfricanAmerican |
3.295000E-01 |
| Caucasian-vs-Asian |
6.183200E-01 |
| AfricanAmerican-vs-Asian |
8.859400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.45479999999576E-05 |
| Male-vs-Female |
2.47759999999486E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.5632999963513E-08 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.70570224611311E-11 |
| Normal-vs-Extreme_Obese |
1.538350E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.883500E-02 |
| Normal_Weight-vs-Obese |
9.787600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.575200E-01 |
| Extreme_Weight-vs-Obese |
1.454230E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.601600E-01 |
| Obese-vs-Extreme_Obese |
4.565800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.313500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.94289029309402E-14 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.84229964617089E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.427200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.755820E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.270300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.201700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.860150E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.255000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
4.59899895943749E-11 |
| Normal-VS-KIRP CIMP |
8.075000E-01 |
| Normal-VS-Unclassified PRCC |
3.94340005094307E-09 |
| Type1 PRCC-VS-Type2 PRCC |
1.781610E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.89829999947189E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
7.592000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.881100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.723200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.142400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66977542903624E-12 |
| Normal-vs-N1 |
3.937700E-03 |
| Normal-vs-N2 |
3.339800E-01 |
| N0-vs-N1 |
1.447510E-02 |
| N0-vs-N2 |
2.877400E-01 |
| N1-vs-N2 |
8.889200E-01 |
|
|
